Post
Endpoints News
endpts.com
did:plc:l5aan5lkmuqstilgyczaho3v
Cartography raised $67M, in part from Pfizer and Amgen’s VC arms, to launch its first trial, mapping a path for its T cell engager in colorectal cancer.
https://endpoints.news/a-year-after-collaborating-with-gilead-cartography-maps-out-its-own-phase-1-with-67m-series-b/?utm_source=Bluesky&utm_medium=organic_social&utm_campaign=editorial&utm_content=
2025-10-02T15:12:48.755Z